Quarterly report pursuant to Section 13 or 15(d)

STOCKBASED COMPENSATION (Tables)

v3.21.1
STOCKBASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2021
STOCK-BASED COMPENSATION  
Schedule of Equity incentive plan

 

 

Awards Reserved

for Issuance

 

 

Awards

Outstanding

 

 

Awards Available

for Grant

 

 

 

 

 

 

 

 

 

 

 

2016 Equity incentive plan

 

 

2,000,000

 

 

 

499,953

 

 

 

1,500,047

 

2018 Equity incentive plan

 

 

43,976,425

 

 

 

11,110,927

 

 

 

32,865,498

 

Schedule of Stock option activity

 

 

Number of

Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Life

 

Aggregate Intrinsic Value of In-the-Money Options

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding as of January 1, 2021

 

 

17,492,830

 

 

$

0.41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

500,000

 

 

$

0.26

 

 

 

 

 

 

Options exercised

 

 

(1,483,334

)

 

$

0.07

 

 

 

 

 

 

Options forfeited

 

 

(4,571,510

)

 

$

0.19

 

 

 

 

 

 

Options expired

 

 

-

 

 

$

-

 

 

 

 

 

 

Options outstanding as of March 31, 2021

 

 

11,937,986

 

 

$

0.53

 

 

8.4 years

 

$

2,108

 

Options exercisable as of March 31, 2021

 

 

7,346,443

 

 

$

0.75

 

 

7.9 years

 

$

883

 

Schedule of Stock based compensation assumptions

 

 

(in thousands except for shares / options)

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

 

 

March 31, 2021

 

 

March 31, 2020

 

Type of Award

 

Number of

Shares or

Options Granted

 

 

Stock-Based Compensation Expense

 

 

Number of

Shares or

Options Granted

 

 

Stock-Based Compensation Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

500,000

 

 

$

244

 

 

 

-

 

 

$

944

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors (common stock)

 

 

541,666

 

 

 

121

 

 

 

 

 

 

 

 

 

Employees (common stock)

 

 

-

 

 

 

-

 

 

 

2,353,115

(*)

 

 

-

 

Non–employee consultants (common stock)

 

 

332,947

 

 

 

33

 

 

 

825,000

(*)

 

 

16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock–based compensation expense

 

 

 

 

 

$

398

 

 

 

 

 

 

$

960